OS Therapies Incorporated (OSTX) Stock Price
OSTXStock
$1.65−37.50%52W
Market Cap$76.68M
P/E—
PEG Ratio—
Div yield—
Beta1.34
OSTX Share Price Chart
Favorite Metrics
Price vs S&P 500 (26W)21.23%
Price vs S&P 500 (4W)0.28%
VGM Score47.87
OSTX Earnings Surprise History
Q2 25-0.19est. -0.12
Q3 25-0.21est. -0.12
Q4 25-0.41est. -0.14
Q1 26-0.27est. -0.19
Q2 26-0.20est. -0.23
OSTX Analyst Recommendations
May 2026
Jun 2026
Jul 2026
Aug 2026
4.10
4.11
4.11
4.10
Industry Peers — Pharmaceuticals(571)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
OSTXOS Therapies Incorporated | — | — | C | $1.65 |
| LLYEli Lilly & Co. | D | B | B | $1233.66 |
| JNJJohnson & Johnson | D | C | B | $273.14 |
| ABBVABBVIE INC. | D | C | B | $265.79 |
| MRKMerck & Co., Inc. | D | C | A | $156.45 |
| NVSNovartis AG | C | C | C | $159.98 |
| AZNAstraZeneca PLC | C | B | C | $169.66 |
| NVONovo-Nordisk A/S | B | C | C | $48.66 |
| ABTAbbott Laboratories | C | C | B | $116.13 |
| PFEPfizer Inc. | C | D | C | $28.57 |
| VRTXVertex Pharmaceuticals Inc | D | C | B | $552.85 |
About OS Therapies Incorporated
OS Therapies is a clinical-stage biopharmaceutical company developing treatments for osteosarcoma and other solid tumors in children and young adults. The company addresses an unmet medical need in pediatric and adolescent bone cancer therapeutics.